47045-PAK-T-MC-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">NULL - Pakistan (01-Jul-2015-31-Dec-2017)</narrative> Pakistan, Tuberculosis, Mercy Corps (MC)This program has the following goals: Contribute to achieving the goal of the national strategy to control TB in Pakistan which is to reduce by 50% the prevalence of TB by 2025 in comparison to 2011. Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treatment. The objectives of this program are: To enhance MDR-TB enrolment from 18% of estimated cases in 2013-14 to 23% of estimated by 2017. To increase TB case notification (all forms) from 61% of estimated incident cases in 2013-14 to 71% of estimated incident cases by 2017 while maintaining treatment success rate at 91%. To increase the number of TB patients who are screened for HIV infection from 3% in 2013-14 to 10% by 2017. The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Izaskun, GAVIRIA Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis 7833228.00 Global Fund Commitment to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 5840360.00 Global Fund Commitment to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 892661.00 Global Fund Commitment to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1194039.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 892661.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1058185.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1913018.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1738760.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1209362.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2175367.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2972088.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1412769.00 Global Fund disbursement to PAK-T-MCP02. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for PAK-T-MCP02</narrative> <narrative xml:lang="en">CM-other 3: Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period in non-NTP providers -private/non-governmental facilit</narrative> <narrative xml:lang="en">CM-other 2 Number of bacteriologically confirmed TB, New and relapse cases, contributed by non-NTP- private/non-governmental facilities</narrative> <narrative xml:lang="en">CM-other 1: Number of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative> <narrative xml:lang="en">Outcome indicators targets and results for PAK-T-MCP02</narrative> <narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative> <narrative xml:lang="en">Case notification rate per 100,000 population- bacteriologically-confirmed TB, new and relapse</narrative> <narrative xml:lang="en">Treatment success rate - bacteriologically confirmed TB cases</narrative> <narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative> <narrative xml:lang="en">Impact indicators targets and results for PAK-T-MCP02</narrative> <narrative xml:lang="en">TB mortality rate per 100,000 population</narrative> <narrative xml:lang="en">TB prevalence rate per 100,000 population</narrative> 47045-PAK-T-MC-5 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Contribution toward achieving the targets of National Strategic Plan for Tuberculosis prevention, care and control in Pakistan - Pakistan (01-Jan-2024-31-Dec-2026)</narrative> Pakistan, Tuberculosis, Mercy Corps (MC)This program has the following goals: To reduce TB mortality rate by 35% in 2026 compared to 2015.. The objectives of this program are: To increase the number of notified new TB episodes to at least 486,160 by 2026 and to maintain TB treatment success rate at more than 90% from 2024 onwards.. To increase the number of detected and treated of MDR/RR-TB cases from 3,373 in 2021 to at least 7,700 by 2026 and their treatment success rate to at least 80% from 2024 onwards.. To increase the proportion of notified TB cases with known HIV status from 52% in 2021 to 100 % by 2026 and to treat 100% of identified TB/HIV with ART every year.. To improve and enhance TB prevention through i) tuberculosis preventive therapy of, at least, 80% of household contacts and PLHIV with no active TB in 2024 to 2026 and ii) strengthening infection control. The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Izaskun, GAVIRIA Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Multicomponent Tuberculosis Multicomponent -> Program management -> Grant management Tuberculosis -> Collaboration with other providers and sectors -> Private provider engagement in TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 12169432.95 12316490.10 10178954.99 21244330.91 Global Fund Commitment to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 215100.00 Global Fund Commitment to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 5968634.00 Global Fund Commitment to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -62048.01 Global Fund Commitment to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -6349487.86 Global Fund Commitment to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 4841476.01 Global Fund Commitment to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 36050.00 Global Fund Commitment to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 3025709.00 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 5336231.08 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 3953783.00 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2882320.00 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1897108.00 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 215100.00 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 36050.00 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2907387.49 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2697441.48 Global Fund disbursement to PAK-T-MCP05. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for PAK-T-MCP05</narrative> <narrative xml:lang="en">Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> <narrative xml:lang="en">TBDT-Other 2: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> <narrative xml:lang="en">Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> <narrative xml:lang="en">Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative> <narrative xml:lang="en">Number of people in contact with TB patients who began preventive therapy</narrative> <narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative> <narrative xml:lang="en">Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> <narrative xml:lang="en">Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative> <narrative xml:lang="en">Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> <narrative xml:lang="en">TBDT-Other 1: Percentage of samples tested using GeneXpert out of the total number of samples transported through specimen transportation</narrative> <narrative xml:lang="en">Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative> <narrative xml:lang="en">Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> 47045-PAK-T-MC-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Contribute towards achieving the targets of National Strategic Plan aligned with End TB Strategy for reducing the burden of TB and MDR-TB in Pakistan - Pakistan (01-Jan-2018-30-Jun-2021)</narrative> Pakistan, Tuberculosis, Mercy Corps (MC)This program has the following goals: Contribute to achieving the goal of the national strategy to control TB in Pakistan which is to reduce by 50% the prevalence of TB by 2025 in comparison to 2011. Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treament. The objectives of this program are: To increase TB case notification (all forms) from 70% of estimated incident cases in 2014-15 to 85% of estimated incident cases by 2020 while maintaining treatment success rate at 91%. To enhance MDR-TB enrollment from 18% of estimated cases in 2014-15 to 33% of estimated by 2020. To increase the number of TB patients who are screened for HIV infection from 3% in 2014-15 to 10% by 2020 The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Izaskun, GAVIRIA Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Multicomponent RSSH Tuberculosis Multicomponent -> COVID-19 -> COVID-19 control and containment including health systems strengthening Multicomponent -> COVID-19 -> Risk mitigation for disease programs Multicomponent -> Payment for results -> Payment for results Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) 3688455.51 6077387.97 3694161.76 6383803.71 -13290.00 Global Fund Commitment to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2719272.54 Global Fund Commitment to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -943834.00 Global Fund Commitment to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 3383374.00 Global Fund Commitment to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 5835494.33 Global Fund Commitment to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -481135.87 Global Fund Commitment to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 5280682.66 Global Fund Commitment to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 3383374.00 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1172555.08 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1922422.89 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 985145.00 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 350821.66 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 835133.00 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1721245.00 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1218876.00 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1549312.57 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 161378.00 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 946873.00 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1546717.46 Global Fund disbursement to PAK-T-MCP03. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -13290.00 Global Fund disbursement to PAK-T-MCP03. Mercy Corps (MC) The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for PAK-T-MCP03</narrative> <narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> <narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> <narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative> <narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> <narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> <narrative xml:lang="en">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> <narrative xml:lang="en">TCP other 1: Number of cases notified through chest camps</narrative> <narrative xml:lang="en">Outcome indicators targets and results for PAK-T-MCP03</narrative> <narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative> <narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative> <narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative> <narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> <narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative> <narrative xml:lang="en">Impact indicators targets and results for PAK-T-MCP03</narrative> <narrative xml:lang="en">TB incidence rate per 100,000 population</narrative> <narrative xml:lang="en">TB mortality rate per 100,000 population</narrative> 47045-PAK-T-MC-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Tuberculosis - Pakistan (01-Oct-2012-30-Jun-2015)</narrative> Pakistan, Tuberculosis, Mercy Corps (MC) The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Izaskun, GAVIRIA Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis 2978263.00 Global Fund Commitment to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 8064554.00 Global Fund Commitment to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -775056.00 Global Fund Commitment to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -960707.00 Global Fund Commitment to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 1633192.00 Global Fund disbursement to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2203207.00 Global Fund disbursement to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 3196659.00 Global Fund disbursement to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2273996.00 Global Fund disbursement to PAK-T-MCP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. 47045-PAK-T-MC-4 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">Contribute towards achieving the targets of National Strategic Plan aligned with End TB Strategy for reducing the burden of TB and MDR-TB in Pakistan. - Pakistan (01-Jul-2021-31-Dec-2023)</narrative> Pakistan, Tuberculosis, Mercy Corps (MC)This program has the following goals: To reduce TB mortality rate by 40% by 2023 compared to 2015. To reduce estimated TB incidence by at least 4% in 2023 compared to 2015. The objectives of this program are: To detect and notify at least 1,300,000 cases of new TB episode during the years 2021 to 2023. To maintain the annual treatment success rate at 90% and over during the years 2021 to 2023. To enroll in treatment with 2nd line TB medicines 21,000 cases of MDR/RR-TB cases during the years 2021 to 2023. To ensure the provision of preventive TB therapy to at least 650,000 eligible people during the years 2021 to 2023 The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division Izaskun, GAVIRIA Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Multicomponent RSSH Tuberculosis Multicomponent -> Payment for results -> Payment for results Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) Tuberculosis -> TB/HIV -> Engaging all care providers (TB/HIV) 15794543.27 8578888.26 8842268.48 -1764946.00 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -35916.79 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2297737.57 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -215100.00 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -4574795.76 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 7843751.00 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -23448.68 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 13140259.88 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -5338206.17 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -215100.00 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 215100.00 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 15786993.18 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -44847.00 Global Fund Commitment to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2808808.83 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2336654.18 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -1764946.00 Global Fund disbursement to PAK-T-MCP04. Mercy Corps (MC) The Global Fund to Fight AIDS, Tuberculosis and Malaria 221553.00 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -215100.00 Global Fund disbursement to PAK-T-MCP04. Mercy Corps (MC) The Global Fund to Fight AIDS, Tuberculosis and Malaria 5303324.00 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -23448.68 Global Fund disbursement to PAK-T-MCP04. Mercy Corps (MC) The Global Fund to Fight AIDS, Tuberculosis and Malaria 4134577.00 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 3917249.96 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 3709174.00 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) -44847.00 Global Fund disbursement to PAK-T-MCP04. Mercy Corps (MC) The Global Fund to Fight AIDS, Tuberculosis and Malaria 4648214.16 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) 2040267.78 Global Fund disbursement to PAK-T-MCP04. Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps (MC) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for PAK-T-MCP04</narrative> <narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative> <narrative xml:lang="en">TCP Other-2: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> <narrative xml:lang="en">Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> <narrative xml:lang="en">Number of people in contact with TB patients who began preventive therapy</narrative> <narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> <narrative xml:lang="en">TCP Other -1: Number of samples tested on Xpert through specimen transportation</narrative> <narrative xml:lang="en">TCP Other- 3: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> <narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> <narrative xml:lang="en">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> <narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> <narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> <narrative xml:lang="en">Impact indicators targets and results for PAK-T-MCP04</narrative> <narrative xml:lang="en">TB incidence rate per 100,000 population</narrative> <narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative> <narrative xml:lang="en">TB mortality rate per 100,000 population</narrative> <narrative xml:lang="en">Outcome indicators targets and results for PAK-T-MCP04</narrative> <narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative> <narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative> <narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative> <narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> <narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>